SINTX TECHNOLOGIES INC (SINT)

US8293927039 - Common Stock

3.52  -0.14 (-3.83%)

Premarket: 3.47 -0.05 (-1.42%)

Fundamental Rating

3

Taking everything into account, SINT scores 3 out of 10 in our fundamental rating. SINT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SINT is valued expensive at the moment.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

SINT had negative earnings in the past year.
SINT had a negative operating cash flow in the past year.
SINT had negative earnings in each of the past 5 years.
In the past 5 years SINT always reported negative operating cash flow.

1.2 Ratios

SINT has a Return On Assets of -103.07%. This is amonst the worse of the industry: SINT underperforms 82.35% of its industry peers.
SINT has a Return On Equity of -208.74%. This is in the lower half of the industry: SINT underperforms 77.01% of its industry peers.
Industry RankSector Rank
ROA -103.07%
ROE -208.74%
ROIC N/A
ROA(3y)-67.03%
ROA(5y)-67.52%
ROE(3y)-145.89%
ROE(5y)-129.23%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SINT's Gross Margin of 66.06% is fine compared to the rest of the industry. SINT outperforms 70.05% of its industry peers.
SINT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.86%
GM growth 5Y11.31%

More info and screens

6

2. Health

2.1 Basic Checks

SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SINT has been increased compared to 1 year ago.
SINT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SINT has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -36.42, we must say that SINT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SINT (-36.42) is worse than 90.91% of its industry peers.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.42
ROIC/WACCN/A
WACC8.97%

2.3 Liquidity

A Current Ratio of 3.04 indicates that SINT has no problem at all paying its short term obligations.
The Current ratio of SINT (3.04) is comparable to the rest of the industry.
SINT has a Quick Ratio of 2.82. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.82, SINT is doing good in the industry, outperforming 60.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.82

More info and screens

6

3. Growth

3.1 Past

SINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.77%, which is quite impressive.
The Revenue has grown by 30.40% in the past year. This is a very strong growth!
The Revenue has been growing by 94.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.1%
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y94.24%
Sales Q2Q%17.85%

3.2 Future

SINT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.83% yearly.
The Revenue is expected to grow by 17.58% on average over the next years. This is quite good.
EPS Next Y97.38%
EPS Next 2Y40.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.65%
Revenue Next 2Y17.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SINT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SINT's earnings are expected to grow with 40.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.83%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SINTX TECHNOLOGIES INC

NASDAQ:SINT (12/20/2024, 8:00:02 PM)

Premarket: 3.47 -0.05 (-1.42%)

3.52

-0.14 (-3.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/dmh
Earnings (Next)01-21 2025-01-21/amc
Inst Owners1.89%
Inst Owner Change-69.57%
Ins Owners0%
Ins Owner Change0%
Market Cap4.72M
Analysts80
Price Target71.4 (1928.41%)
Short Float %6.24%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.81%
Min EPS beat(2)75.98%
Max EPS beat(2)99.64%
EPS beat(4)4
Avg EPS beat(4)63.65%
Min EPS beat(4)29.97%
Max EPS beat(4)99.64%
EPS beat(8)4
Avg EPS beat(8)-37.2%
EPS beat(12)7
Avg EPS beat(12)-19.59%
EPS beat(16)10
Avg EPS beat(16)-11.77%
Revenue beat(2)2
Avg Revenue beat(2)16.19%
Min Revenue beat(2)11.9%
Max Revenue beat(2)20.48%
Revenue beat(4)3
Avg Revenue beat(4)6.85%
Min Revenue beat(4)-15.39%
Max Revenue beat(4)20.48%
Revenue beat(8)5
Avg Revenue beat(8)5.83%
Revenue beat(12)7
Avg Revenue beat(12)10.06%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-557.8%
EPS NY rev (1m)2.88%
EPS NY rev (3m)87.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-31.02%
Revenue NY rev (1m)4.19%
Revenue NY rev (3m)4.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-93.14
EYN/A
EPS(NY)-12.06
Fwd EYN/A
FCF(TTM)-8.41
FCFYN/A
OCF(TTM)-7.94
OCFYN/A
SpS2.42
BVpS4.16
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.07%
ROE -208.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.06%
FCFM N/A
ROA(3y)-67.03%
ROA(5y)-67.52%
ROE(3y)-145.89%
ROE(5y)-129.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.86%
GM growth 5Y11.31%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.17%
Cap/Sales 19.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.04
Quick Ratio 2.82
Altman-Z -36.42
F-Score4
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)813.08%
Cap/Depr(5y)602.07%
Cap/Sales(3y)242.39%
Cap/Sales(5y)161.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.1%
EPS Next Y97.38%
EPS Next 2Y40.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y94.24%
Sales Q2Q%17.85%
Revenue Next Year20.65%
Revenue Next 2Y17.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.77%
OCF growth 3YN/A
OCF growth 5YN/A